Skip to main content
Clinical Trials/NCT04170699
NCT04170699
Completed
Not Applicable

Effects of Ultrasound Guided Pectoral Blok Type 1 on Subcutaneous Port Catheter Replacement : A Randomized Controlled Study

Bulent Ecevit University1 site in 1 country120 target enrollmentJanuary 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Catheter; Pain (Indwelling Catheter)
Sponsor
Bulent Ecevit University
Enrollment
120
Locations
1
Primary Endpoint
Perioperative and postoperative analgesic needs of patients
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

In this study our aim is to investigate the effects of ultrasound (USG) guided pectoral block (PECS) type 1 in the administration of an implanted port-a-cath .

Detailed Description

Cancer is one of the most important reasons of mortality in the world. There are a lot of different types of treatments for cancer and so far chemotherapy is the most common one. However, chemotherapy damages the peripheral veins, so implanted subcutaneous port-a-caths are used as an alternative. Traditionally this implantation is adminstered with infiltrative anesthesia. Recently, USG is used in anesthesia practice world wide. Blanco R et all (1) defined PECS 1 block as an alternative to paravertebral block. PECS 1 block aims to anesthetize the medial and lateral pectoral nerves. In this study our aim is to investigate the effects of USG guided PECS 1 block in the administiration of an implanted port-a-cath .

Registry
clinicaltrials.gov
Start Date
January 1, 2019
End Date
December 31, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Bulent Ecevit University
Responsible Party
Principal Investigator
Principal Investigator

OZCAN PISKIN, MD

ASSOCIATED PROFFESOR OZCAN PISKIN M.D.

Bulent Ecevit University

Eligibility Criteria

Inclusion Criteria

  • Ages between 18- 75
  • ASA (American Society of Anesthesiologists) Score I-IV
  • Undergoing elective port-a-cath replacemnet

Exclusion Criteria

  • Patients with neurological deficits
  • Patients who have major vascular damage at the same side
  • Mentally retarded patients
  • Patients with alcohol or drug addiction
  • Patients who are allergic to local anesthetics
  • Pregnancy
  • Paitents with coagulopathy
  • Patients with skin infection at the side of the procedure
  • Patients with pneumothorax at the side of the procedure
  • Patient with a pacemaker

Outcomes

Primary Outcomes

Perioperative and postoperative analgesic needs of patients

Time Frame: Change in Visual analog Scale (VAS) scores ( between 1 and 10, a higher score represents greater pain intensity. ) at the 1st, 3rd, 6th, 12th and 24th hours after the procedure.

Our primary outcome is to measure and identify the analgesic needs of the patients at the perioperative and postoperative period.In order to measure the analgesic needs Visual Analogue Scale will be used and patients' pain scores will be measured.

Secondary Outcomes

  • Hemodynamic parameters at the perioperative and postoperative period(1st, 3rd, 6th,12th and 24th hours after the procedure.)

Study Sites (1)

Loading locations...

Similar Trials